PracticeUpdate
@practiceupdate
Followers
5K
Following
10K
Statuses
22K
PracticeUpdate is a free website by Elsevier curating content for healthcare professionals by our medical experts to help improve patient care.
New York, NY
Joined November 2012
RT @johnwmcevoy: Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for Initial Hypertension Treatment
0
3
0
0
5
0
RT @BenoitChassaing: Dietary emulsifiers in IBD — the gun is not yet smoking but it is hot !!!! From @HeloiseRytter from @institutpasteur…
0
8
0
RT @Annals_Oncology: 📢#ESMO24 concomitant paper: A fascinating editorial from the Keynote presentation “How AI will transform cancer care”…
0
6
0
RT @Annals_Oncology: 📢#ESMO24 concomitant paper: Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase 3 K…
0
5
0
RT @Annals_Oncology: 📢#ESMO24 concomitant paper: Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase 3 K…
0
2
0
RT @Annals_Oncology: 📢#ESMO24 concomitant paper: Ipilimumab and Nivolumab in molecular-selected mCRPC - primary analysis of the phase 2 IN…
0
1
0
RT @Annals_Oncology: 📢#ESMO24 concomitant paper: Ipilimumab and Nivolumab in molecular-selected mCRPC - primary analysis of the phase 2 IN…
0
2
0
RT @Annals_Oncology: 📢#ESMO24 concomitant paper: A fascinating editorial from the Keynote presentation “The global epidemic of early-onset…
0
1
0
RT @Annals_Oncology: 📢#ESMO24 concomitant paper: A fascinating editorial from the Keynote presentation “The global epidemic of early-onset…
0
7
0
RT @Annals_Oncology: 📢 #ESMO24 concomitant paper: Osimertinib after definitive CRT in unresectable stage III EGFR-mutated NSCLC: CNS effica…
0
4
0
RT @Annals_Oncology: 📢 #ESMO24 concomitant paper: Osimertinib after definitive chemoradiotherapy in unresectable stage III EGFR-mutated NSC…
0
5
0
RT @Annals_Oncology: 📢 #ESMO24 concomitant paper: First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTA…
0
8
0
RT @Annals_Oncology: 📢 #ESMO24 concomitant paper: First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTA…
0
2
0
RT @Annals_Oncology: 📢#ESMO24 concomitant papers: Watch extended video commentaries from our concomitant paper authors👏👏👏
0
1
0
Webinar: Spatial insights in cancer: From gene expression to molecular atlases w/ speakers Joakim Lundeberg @scilifelab @JoakimLundeberg, Elana Fertig @FertigLab @hopkinskimmel @JohnsHopkins & Ahmet Coskun @ahmetfcoskun @GeorgiaTech. Sept 26; 12:00 pm ET
0
0
0
RT @CellPressNews: Don’t miss tomorrows webinar, Tools and applications of flow cytometry w/ Evan Newell @fredhutch @EvNewell1 & Nima Aghae…
0
1
0
RT @CellPressNews: Free Cell Press webinar, Tools and applications of flow cytometry w/ speakers Evan Newell @fredhutch @EvNewell1 & Nima A…
0
8
0
Did you know rate control by itself is no longer felt to be an appropriate first-line strategy for most AF patients? Watch leading experts discuss strategies to prevent AF progression: #cardiology #AFib #AF #atrialfibrillation #rhythmcontrol #cardiaccare
0
0
0
[WATCH] Dr. Kamala P. Tamirisa + other #cardiac care experts discuss the use of ablation and AADs individually and as complementary treatments for rhythm control in patients with AF now: #AFib #atrialfibrillation #cardiaccare #primarycare #ablation
0
0
0